Structure and Function of Mammalian Centromere Section, LBC
Laboratory of Biosystems and Cancer, Division of Basic Sciences, National
Cancer Institute, NIH
Building 49, Room 4A56
301-496-7948
Summary of Research:
Our work can be divided into two interrelated parts. We are studying the
general organization of centromeric regions of human chromosomes. The major
focus of the research being conducted in our laboratory is to determine
minimal structural requirements for functional centromere and to generate
a portable human artificial chromosome (HAC) for gene delivery. We
are also working on isolation and characterization of human disease genes.
Ongoing work is presently focused on two major areas of research.
The Organization of Human Centromere
The mammalian centromere is a specialized region of the chromosome, which
controls proper chromosome segregation. Structural studies of mammalian
centromeres have shown that they contain long stretches of tandemly repeated
DNA sequences. These regions represent approximately 15% of human genome.
Despite their importance, centromeres remain poorly understood and even
a new released human genome sequence does not contain information on centromeric
regions. Previously it was thought that this fraction of genome lacks genes
and represents a junk DNA. Recent identification of functional copies of
genes within centromeric regions of plant chromosomes raises the question
that human centromeres spanning several megabases may be organized similarly.
The main reason why centromeres remain poorly understood is that long stretches
of tandemly repeated centromere-specific DNA sequences can not be cloned
by a standard technique and they are unstable during propagation in both
bacterial and yeast hosts. We developed a novel approach for isolating
of centromeric regions based on specific targeting of centromeric DNA and
the following rescue of the targeting region as a set of large yeast artificial
chromosomes (YACs). This new cloning strategy was applied for studying
several centromeric regions including a centromeric region of a mini-chromosome
containing ~5 Mb of the human chromosome Y. William Brown and co-authors
(University of Oxford) generated this mini-chromosome by two rounds of
telomere-directed chromosome breakage leading to a loss of sequences from
both arms of the chromosome. Despite the small size and loss of a
significant part of centromeric repeats (only 140 kb of alphoid DNA was
left), the mini-chromosome segregates accurately in mitosis, suggesting
that this block of alphoid DNA alone or along with the short arm flanking
sequence is sufficient for a centromere function. As a first step
to construct Human Artificial Chromosome (HAC) the centromeric region of
the mini-chromosome was TAR rescued in yeast as a circular YAC and its
complete sequence was determined. For further functional analysis
the YAC was retrofitted into a YAC/BAC with a mammalian selectable marker.
When transfected into human cells, this circular DNA construct is stably
maintained at 1-2 copies per cell. We are in progress to investigate the
HAC as a vector for megabase-size genes and as a model for studying a human
kinetohore.
The Organization and Expression of Human Diseases Genes
The mammalian gene function analysis is impeded by the lack of a convenient
expression system. Attempts to express human genes using cDNA expression
vectors frequently result in cell cycle arrest as a result of uncontrolled
expression of the genes in transfected cells. It is obvious that a genomic
copy of the genes with all regulatory elements (including potential regulatory
elements in intron regions) instead of surrogate cDNA constructs would
be preferential for gene expression studies. However, routine large
insert size cloning techniques (BAC and YAC) produce clones with random
genomic fragments and the gene of interest is either available only
as a set of overlapping genomic fragments that form a contig or available
as a large genomic fragment carrying other genes. A new approach
referred to as TAR (Transformation-Associated Recombination) cloning has
recently emerged, which allows entire genes and large chromosome regions
to be specifically and accurately isolated from total genomic DNA. This
nonenzymatic procedure for DNA cloning is based on in vivo recombination
in the yeast S. cerevisiae, an organism that exhibits a high level of intermolecular
recombination between homologous DNAs during transformation.
Over the last two years we successfully applied the new technique for isolation
of entire copies of several human genes including breast cancer genes,
BRCA1 and BRCA2, the metastasis-suppressor gene KAI1, the telomerase reverse
transcriptase gene hTERT and a paternally expressed gene Ubiq. We are in
progress to investigate regulation of expression of these genes using a
recently developed Human Artificial Chromosome (HAC) as a gene delivery
system.
Collaborators on this research are: Carl Barrett, Ph.D.,
Division of Basic Sciences; Mitsuo Oshimura, Ph.D., Tottori University,
Japan; David Schlessinger, Ph.D., National Institute on Aging; Lisa Stubbs,
Ph.D., Livermore National Laboratory; Pieter deJong, Ph.D., Roswell Park
Cancer Institute; Bob Moyzis, Ph.D., University of California at Irvine;
Peter Warburgton, Ph.D., Mount Sinai School of Medicine; William Brown,
Ph.D., University of Oxford; Andy Choo, Ph. D., Murdoch Institute for Research
into Birth Defects.
Staff:
Vladimir Larionov, Ph.D., Acting Head
Natalay Kouprina
Vladimir Noskov
Maxim Koriabine
Prepared by Cynthia L. Gordon
Updated: 11/6/00
Return to [ LBC
Home Page | Division
of Basic Sciences | NCI Home Page
]